The transcriptional repressor Tbx3 is involved in lineage specification in several tissues during embryonic development. Germ-line mutations in the Tbx3 gene give rise to Ulnar-Mammary Syndrome (comprising reduced breast development) and Tbx3 is required for mammary epithelial cell identity in the embryo. Notably Tbx3 has been implicated in breast cancer, which develops in adult mammary epithelium, but the role of Tbx3 in distinct cell types of the adult mammary gland has not yet been characterized. Using a fluorescent reporter knock-in mouse, we show that in adult virgin mice Tbx3 is highly expressed in luminal cells that express hormone receptors, and not in luminal cells of the alveolar lineage (cells primed for milk production). Flow cytometry identified Tbx3 expression already in progenitor cells of the hormone-sensing lineage and co-immunofluorescence confirmed a strict correlation between estrogen receptor (ER) and Tbx3 expression in situ. Using in vivo reconstitution assays we demonstrate that Tbx3 is functionally relevant for this lineage because knockdown of Tbx3 in primary mammary epithelial cells prevented the formation of ER+ cells, but not luminal ER-or basal cells. Interestingly, genes that are repressed by Tbx3 in other cell types, such as E-cadherin, are not repressed in hormone-sensing cells, highlighting that transcriptional targets of Tbx3 are cell type specific. In summary, we provide the first analysis of Tbx3 expression in the adult mammary gland at a single cell level and show that Tbx3 is important for the generation of hormone-sensing cells.
Introduction
Tbx3 is a transcriptional repressor with an important role in embryonic development of the mammary gland and a high expression in certain breast cancers, but its role in the different cell types of adult mammary epithelium has yet to be explored [1] . Mammary gland development starts in the embryo, but the largest part occurs postnatally. During murine embryogenesis, an ectodermal mammary placode is induced which develops into a rudimentary epithelial tree [2] . During puberty, under the influence of steroid hormones, the epithelial ducts start to elongate and bifurcate to fill the mammary fat pad [3] . In the adult, morphogenesis of the mammary gland continues as it is subject to further branching and the development of lobular structures with alveoli (milk-producing units) during pregnancy, culminating in lactation, followed by regression and remodelling to a virgin-like state after weaning. At a smaller scale, there is even some alveologenesis and regression under the influence of hormonal fluctuations during the estrus cycle [3] .
Milk ducts in the adult virgin are bi-layered with a luminal layer that consists of hormone-sensing cells and cells primed for milk production (alveolar progenitor cells) and an outer basal layer that contains mostly contractile myoepithelial cells, but also rare mammary epithelial stem cells [4] . Both these multipotent stem cells as well as lineage-restricted populations contribute to epithelial renewal and alveologenesis [5] [6] [7] . In transplantation assays, a progenitor that gives rise to all cells types of an alveolus can be detected [8] , but recent data by several groups [7, 9, 10] highlights that in intact mammary glands alveoli are commonly formed by collaborative outgrowth of cells from at least 3 distinct lineages. This includes cells from the basal lineage, the luminal estrogen receptor-negative (ER-) alveolar lineage and the luminal ER+ hormone-sensing lineage [10] . The latter was unexpected, since hormone-sensing cells have been considered mature, or terminally differentiated cells. However several reports have shown that hormone-sensing cells actively proliferate in vivo in early pregnancy [11, 12] . In addition, ER+ progenitor cells have recently been identified by cell surface markers and in vitro colony forming potential [13, 14] , indicating that it is indeed a separate lineage. The regulation of the hormone-sensing lineage is particularly interesting because the majority of breast cancers express the estrogen receptor [15, 16] .
Here, we analyzed the role of Tbx3 in the lineage hierarchy of the adult mammary gland. Tbx3 is one of the earliest markers of mammary epithelial cells in embryonic development, and in the absence of Tbx3 embryonic mammary placodes fail to form [17] . In Tbx3-heterozygote mice, reduced expression of Tbx3 is sufficient to allow normal mammary gland development [17] , although a later study showed that in thoracic mammary glands epithelial trees occasionally did not form and fewer branches were observed in the adult glands [18] . In humans, hypomorphic germline mutations in the Tbx3 gene are the cause of UlnarMammary Syndrome [19] in which reduced activity of Tbx3 results in reduced breast development, in addition to other developmental defects [20] . Thus, even though there appear to be differential quantitative requirements for Tbx3, Tbx3 plays an important role in early mammary gland development across species. Tbx3 is also involved in the embryonic development of numerous other tissues, including limbs, heart and liver [21, 22] .
Tbx3 is likely to play a role in adult tissues as well, because Tbx3 has been implicated as an oncogene [23, 24] and was found overexpressed in cell lines from several cancer types, including melanoma and hepatoma [24, 25] . In breast cancer, high nuclear and cytoplasmic expression of Tbx3 was found in a subset of cells in primary tumors [26] and high transcriptional Tbx3 levels in human breast tumors correlated strongly with ER expression [27] . Here, we investigated the expression of Tbx3 in the different mammary epithelial cell types in the adult mammary gland.
Materials and Methods

Ethics statement
Mice used in this study were maintained under protocols which were approved by the legal authority of the Singhealth Institutional Animal Care and Use Committee, Singapore. All procedures were in accordance with its guidelines. Non-terminal procedures were performed under anesthesia, and all efforts were made to minimize suffering of the animals. Anesthesia (Hypnorm:Midazolam:Water = 1:1:2) was administered at 7 ml/kg and analgesia (Meloxicam) was administered at 0.2 mg/kg. Further analgesia (Meloxicam) was added to the drinking water for 2-3 days after surgery (,0.2 mg/kg). Animals were euthanized by carbon dioxide inhalation followed by cervical dislocation. All efforts were taken to prevent animal suffering.
Mice
Tbx3 tm1(Venus)Vmc (synonym: Tbx3 Venus ) mice were generated by inserting the Venus coding and transcription termination/pA sequences into the start codon of Tbx3. This places Venus under control of the endogenous Tbx3 locus and prevents expression of Tbx3 itself. A detailed description of the generation of these knock-in mice is in preparation and will be described elsewhere (MLB and VMC). Heterozygous Tbx3 +/Venus mice were maintained on an FVB background. Mice were euthanized by carbon dioxide inhalation and immediately dissected for thoracic (MG3), abdominal (MG4 & 5) mammary glands. Animal care and protocols were in accordance with national and institutional guidelines.
Cell labeling, flow cytometric analysis & fluorescence-activated cell sorting (FACS)
Abdominal glands were pooled and processed for single mammary epithelial cell (MEC) isolation for FACS analysis as previously described [28] . Fluorochrome-conjugated antibodies were titrated on primary mammary epithelial cells to ensure maximal positive signal:background fluorescence ratio. Antimouse &/or anti-rat compensation beads (BD 552843 and 552845, respectively) were used for single stain antibody controls. Compensation controls also included two cellular samples: unstained cells and cells stained with DAPI (Sigma D8417, USA). Cells were incubated with antibodies on ice for 45 minutes with agitation every 15 minutes. Samples were then washed with twice the sample volume and resuspended in L15 (Gibco-Life Technologies, USA) with 6% FCS (Hyclone, USA) and 200 ng/ mL of DAPI, except non-DAPI compensation controls. All multiple-labelled samples were gated on FSC-A vs. SSC-A and doublet discrimination (FSC-H vs. FSC-W & SSC-H vs. SSC-W) and DAPI negativity. Samples contained anti-CD45 to exclude lymphocytes from analysis. Cells were analyzed and sorted on a BD FACS-Aria II containing 355 nm UV, 488 nm blue, 561 nm yellow-green and 633 nm red lasers. Specific antibodies used and gating strategy are detailed in File S1.
Synthesis of cDNA & qPCR analysis
For analysis of transcript levels by qPCR in FACS sorted populations, cells were sorted directly into lysis buffer (10 IU RNase inhibitor (Invitrogen, USA), 2 mM DTT, 0.15% Tween-20 (Biorad, USA) in 12 mL of nuclease-free water) in PCR tubes using a Direct Reverse Transcription method as described [29] . Five-hundred cells were sorted into each tube and Reverse transcription (RT) was performed using Superscript VILO (Invitrogen, USA) as per manufacturers protocol. Primers were designed that span introns to exclude the detection of genomic DNA and selected for optimum melt curve and amplification profiles (for primer sequences, see File S2). qPCR was performed using Sso Fast Evagreen supermix reagent (Biorad #172-500) as per manufacturers protocol.
For microarray analysis, MECs from 3 Tbx3 +/Venus adult virgin mice were pooled and 200,000 luminal Venus High and luminal Venus Low cells were sorted into L15 medium with 6% FCS. After centrifugation, cell pellets were lysed in Trizol and total RNA was isolated according to manufacturers protocol. Biotinylated cRNA was prepared from 250 ng of total RNA with the GeneChip 39 IVT Express Kit according to the manufacturers protocol (Affymetrix 2008). Following fragmentation, 12.5 ug of cRNA was hybridized on a GeneChip Mouse Genome 430 2.0 Array for 16 hours at 45 C. The GeneChip was washed and stained in the GeneChip Fluidics Station 450 (Affymetrix) and scanned using the GeneChip Scanner 3000 7 G (Affymetrix). A log 2 base transformation was applied before the data was normalized. Normalization and centering of all genes for each sample was performed by BRB Array software. The data is deposited as GEO series GSE58327.
Indirect immunofluorescence
Thoracic mammary glands were fixed for 24 hours in 4% paraformaldehyde and embedded in paraffin wax. Paraffin sections of 5 mm were prepared and subjected to 1 mM disodium-EDTA antigen retrieval as described previously [28] . Primary antibodies used for immunofluorescence are the following: Cytokeratin 8 (Developmental Studies Hybridoma Bank TROMA-I, rat, 1:100), Estrogen receptor (Novocastra NCL-ER-6F11, mouse, 1:100), E-Cadherin (BD Biosciences 610181, mouse, 1:250), Progesterone receptor (Abnova MAB9785, rabbit, 1:400), Smooth muscle actin (Sigma A2547, mouse, 1:1000), Tbx3 (Invitrogen 424800, rabbit, 1:100), turboGFP (Pierce Antibodies PA522688, rabbit, 1:400), turboGFP (OriGene TA150041, mouse 1:250). Secondary antibodies used at 1:400 dilution are from Invitrogen: Alexa488-coupled goat anti-mouse (A11029), Alexa488-coupled goat anti-rabbit (A11034), Alexa568-coupled goat anti-mouse (A11031) and Alexa568-coupled goat anti-rabbit (A11036). Additionally, CF633nm-coupled donkey anti-rat (Biotium 20137-1) was used at 1:400 dilution. Images were acquired on a Zeiss LSM-710 confocal microscope with a pinhole aperture of 1 Airy unit.
Colony forming assays
For analysis of colony forming potential, a pool of 4-6 Tbx3 +/ Venus mice between the age of 10 to 16 weeks were used. One thousand sorted cells were seeded into 22.1 mm (12-well) plate with 0.7521610 6 NIH-3T3 feeder cells that had been treated with mytomycin C (10 ug/ml) (Sigma, M4287). Colonies were cultured for 5-6 days in MEC medium, consisting of DMEM:F12 medium (Invitrogen, 11320033) supplemented with Penicillin Streptomycin (Gibco, 15140), 6% FCS (Hyclone, SV30160.03), 5 ng/ml cholera toxin (Sigma, 8052), 5 ug/ml Insulin (Sigma, 16634) and 10 ng/ml EGF (Sigma, E4127). At the end of the assay colonies were fixed in 4% paraformaldehyde and stained with 1 mg/ml crystal violet (Sigma, C3886) in 50% dH 2 0: 50% methanol. Images were acquired on a Olympus IX71 inverted microscope.
Lentiviral vector construct & production
Several short hairpins against murine Tbx3 were cloned into a MSCV-blast vector using a miR30 backbone and tested for knock down efficiency in HC11 cells. The two best shRNAs (see File S2) were digested with SalI and MluI and ligated into the GIPZ cloning vector (Trans-Lentiviral Packaging kit TLP4616, Thermo Scientific Open Biosystems) digested with XhoI and MluI (New England Biolabs). Lentiviral particles were produced by cotransfecting 32 ug of GIPZ plasmid (non-silencing or with a shRNA against Tbx3), 10 ug of pSuper-Drosha (to reduce processing of the RNA during packaging) and 30 ug packaging plasmids (TLP mix) into HEK293T (HCL4517, Thermo Scientific Open Biosystems) using the calcium phosphate method according to the manufacturers' protocol.
Transplantation
Abdominal mammary glands were harvested from 5 wildtype FVB (experiment 1) and 4 KI (Tbx3 +/Venus ) donor mice (experiment 2). The mammary glands were digested to single cells and plated at 5610 5 cells/well in a 6-well plate. Cells were adhered overnight in 3% oxygen and the next day cells were subjected to spin transduction. Viral supernatant was diluted in MEC medium at a 2:1 ratio, added to the cells at 1.5 ml/well and spun at 2000 rpm for 30 minutes at 32uC. After centrifugation, the cells were returned to the incubator (5% CO2 and 3% O2). The next morning, cells were washed thrice with PBS and trypsinized, spun and re-suspended in 10-20 ml MEC medium. Cells from one well were injected into cleared MG4 fat pads of 21-day old matched recipient mice and allowed to engraft for 10 weeks [30] . Glands were then harvested, fixed in methacarn (60% methanol, 30% chloroform, 10% acetic acid) or 4% paraformaldehyde for 24 hours and embedded in paraffin.
Results
Tbx3 is differentially expressed in mammary epithelial cellular subsets
To investigate Tbx3 expression in the different mammary epithelial cell (MEC) types, we made use of a reporter mouse strain in which one of the Tbx3 alleles had been replaced with the gene for Venus, a variant of yellow fluorescent protein (Tbx3 +/Venus , also referred to as knock-in (KI) mice). We isolated primary MECs from Tbx3 wildtype and KI females and analyzed them by flow cytometry. After excluding dead cells, lymphocytes and stromal cells (see gating strategy in File S1), the epithelial cells segregated in three distinct peaks based on Venus signal intensity ( Figure 1A ). Venus expression accurately reflected Tbx3 transcription in the three different peaks, with the highest Tbx3 mRNA levels in the cells with the highest Venus fluorescence ( Figure 1B) .
To identify the cell type with high Tbx3 expression, we separated MECs into cells of the luminal layer (CD24   hi   CD49f lo , blue) and basal layer (CD24   l   uCD49f hi , red, Figure 1C ). When the luminal and basal cellular subsets are plotted separately, it is apparent that the peak with intermediate Venus signal reflected basal cells, and that luminal cells were divided into a subset with high and one with low Tbx3 promoter activity ( Figure 1D ). This distribution is quantified in independent animals in Figure 1E . Plotting the populations with distinct Venus intensities on a CD24/CD49f contour plot further illustrates the division of the luminal population based on Tbx3 expression ( Figure 1F ).
High Tbx3 expression in hormone-sensing cells
Epithelial cells in the luminal layer fall into two main functional categories, hormone-sensing (HS) cells and alveolar progenitor cells and these can be separated by flow cytometry using the additional cell surface markers Sca1 and CD49b (Figure 2A ). The proportion of HS and alveolar progenitor cells in Tbx3 +/Venus mammary epithelium is similar to that in wildtype litter mates ( Figure 2B ), indicating that Tbx3 heterozygosity does not affect the composition of the luminal layer. This could be the result of relatively high Tbx3 mRNA levels in the heterozygote KI cells (75% of wildtype cells, Figure 2C ), which might suggest that Tbx3 is involved in a negative transcriptional feedback loop. This experiment also demonstrated that Tbx3 expression is highest in the HS population ( Figure 2C ), raising the question whether the cells with highest Tbx3 expression are all hormone-sensing cells. Plotting luminal cells based on their Tbx3 expression showed that indeed almost all Venus High cells were part of the HS cell population whereas almost all Venus Low cells belonged to the alveolar progenitor cell population ( Figure 2D ). Similarly, separating the luminal population based on cell type also showed that the majority of the HS cell population was Venus High and the alveolar progenitor population was Venus Low ( Figure 2E ). The correlation between high Tbx3 expression and a hormone-sensing cell identity was confirmed by transcriptional analysis by microarray using cells pooled from three animals and separated by Venus fluorescence (File S3) and by qPCR on luminal populations sorted from individual KI animals ( Figure 2F ). Luminal cells with low levels of Venus and Tbx3 expressed variable but high levels of Elf5, a transcription factor that specifies alveolar cell fate [31] , and beta-Casein, one of the components of milk ( Figure 2E ). Luminal cells that expressed high levels of Tbx3 had high levels of Sca1 transcription, in line with the flow cytometry profiles, and expressed high levels of the estrogen and progesterone receptor, thereby confirming the hormone-sensing identity of Tbx3-expressing luminal cells at the molecular level.
Tbx3 expression marks the hormone-sensing cell lineage
In the non-pregnant adult mammary gland, proliferation is detected mostly in ER-luminal cells, and this is mirrored by their colony forming potential when plated on feeder layers [13, 32] . Similarly, when we sorted mammary epithelial cells from adult virgin mice, we found that luminal cells form more colonies than basal cells ( Figure 3A, 3B) . The luminal colony-forming potential was derived almost entirely from Tbx3-Venus Low cells ( Figure 3C , 3D) as expected based on their alveolar ER-cell identity. Luminal cells with high Tbx3 expression lacked colony-forming potential ( Figure 3D ), consistent with other reports that show that the HS cell population is non-clonogenic [13, 33] . Nevertheless, Shehata and colleagues recently identified a small subset of hormonesensing progenitor cells that expressed high levels of alpha2-integrin (Sca1 hi CD49b hi ) and formed colonies on feeder cells [13] . Analyzing this ER+ progenitor population separately demonstrated that the majority of these cells belonged to the Tbx3-Venus High population (94%63%, Figure 3E ) and mRNA levels of both Tbx3 and hormone receptors in Sca1 hi CD49b hi cells were comparable to that of the general hormone-sensing cell population ( Figure 3F ). In line with previous studies [13, 14] , the ER+ progenitor population is distinct in that it also expressed low levels of Elf5 and c-Kit. Luminal cells with high Tbx3 expression (Venus High ) that fell into the Sca1 hi CD49b hi gate had robust colony forming potential ( Figure 3G , quantified in Figure 3H ), confirming the progenitor potential of this population. These experiments showed that Tbx3 expression is already high in the earliest recognizable cell type of the hormone-sensing lineage.
Taken together, analysis of the Tbx3 +/Venus reporter by flow cytometry combined with functional assays demonstrates that in the luminal layer of mammary epithelium Tbx3 expression distinguishes the hormone-sensing cell lineage from the secretory alveolar lineage.
Tbx3 protein expression in intact mammary glands
To further evaluate whether the strict correlation between transcriptional expression of both Tbx3 and ER that we observed by FACS holds true at the protein level in intact mammary glands, we used co-immunofluorescence on paraffin sections from adult virgin mice. The Tbx3 antibody gave high background staining in the stroma, but clearly confirmed the existence of cells in the At the transcriptional level, basal cells displayed intermediate Tbx3 expression (Figure 1D ). On paraffin sections, it was difficult to detect Tbx3 protein in cells of the basal layer (identified by the basal marker smooth muscle actin, see Figure 4B ). This could be due to post-transcriptional regulation by for instance microRNAs, but it could also be a technical limitation of the sensitivity of detection. In the luminal layer, cells strongly express E-cadherin, including the hormone-sensing cells with high Tbx3 expression ( Figure 4C ). Tbx3 was found to repress E-cadherin in melanoma cells [24] , but it does not appear to do so in mammary epithelial cells. Previous studies have shown that Tbx3 is involved in development of the rudimentary mammary gland during embryogenesis [17] , a process that is steroid hormone independent [3] . During puberty, steroid hormones induce the elongation of mammary epithelial ducts. The invasive tips of elongating milk ducts are called Terminal End Buds (TEBs) and we examined the pattern of Tbx3 expression in these structures using mammary glands from pubertal mice. Similar to the adult mammary gland, Figure 5A ). However in puberty the occurrence of ER+ cells without Tbx3 (2.6%63.4%) was more prevalent compared to the adult virgin, and in puberty there were some Tbx3-positive cells without detectable ER expression (4.3%61.7%). The staining for Tbx3 appeared more intense in TEBs compared to quiescent adult mammary tissue ( Figure 5B ). In puberty, a considerable proportion of ER+ cells is proliferating [34] , in contrast to the quiescent adult stage. In early pregnancy, ER+ cells also proliferate [11] but Tbx3 levels did not seem elevated during this stage of active morphogenesis ( Figure 5C ). At day 3 of pregnancy, there appeared to be a near perfect correlation between ER and Tbx3, similar to the adult virgin. However, due to a lower staining intensity for both ER and Tbx3 at this stage putative cells that express only one or the other might be more difficult to detect.
Together, these experiments show that Tbx3 expression consistently distinguishes hormone-sensing cells from ER-luminal cells, not only by flow cytometry but also in unperturbed mammary tissue at different developmental stages.
Tbx3 is required for the hormone-sensing cell lineage
To determine if Tbx3 expression is functionally relevant for the hormone-sensing cell lineage, we designed two short hairpins that target distinct regions of the murine Tbx3 transcript. The reduction in Tbx3 mRNA by the shRNAs was confirmed in a mouse mammary epithelial cell line (HC11) after selection of lentivirally-transduced cells by puromycin (File S4A). Next, freshly isolated MECs were incubated with lentiviral vectors overnight and transplanted (without selection) into mammary fat pads devoid of endogenous epithelium (see File S4B for the experimental design). Eight to ten weeks after reconstitution, we examined the identity of the cells that were transduced by lentiviral vectors (as indicated by their turboGFP (tGFP) expression). Outgrowths from cells that had been exposed to the control virus illustrated that the majority of transduced cells were lineagerestricted progenitors; we rarely found ducts whereby all cell types were tGFP positive. Instead, we found ducts that contained tGFP+ cells that predominantly belonged to one lineage (either luminal ER-or ER+ or basal, see File S5). For these experiments, we used two different pools of donor cells; one consisting of wildtype MECs +/Venus MECs to potentially facilitate further knockdown. Importantly, in both cases the pool of cells transduced with the control vector gave rise to cells of all different lineages, including ER+ hormone-sensing cells (Figure 6A&B). Cells with Tbx3 knockdown robustly gave rise to luminal ER-cells, but there was a strong bias against the generation of hormone-sensing cells ( Figure 6C&D ). This was true for both the wildtype and KI cells and for both short hairpins targeting Tbx3 ( Figure 6A ). In both control and Tbx3 knockdown outgrowths we found some tGFP+ cells that contributed to cells of the basal layer but this proportion was too low for accurate quantification. The lack of adverse effects of Tbx3 knockdown in the Tbx3
Low alveolar lineage and the strong effect in the Tbx3-positive hormone-sensing lineage demonstrate that Tbx3 expression is important for the generation of hormone-sensing cells.
Discussion
Tbx3 is required for mammary epithelial cell identity early in embryogenesis, but its role in the different mammary epithelial cell types of the adult mammary gland had not yet been determined. Using a novel reporter mouse strain, we show that Tbx3 transcriptional expression is tightly regulated at different levels in the three main epithelial lineages; high in hormone-sensing cells, very low in alveolar progenitor cells and intermediate in basal cells.
Based on the striking bimodal distribution of Tbx3 in the luminal population, we focused our analysis in this study on the role of Tbx3 in luminal mammary epithelial cells. During embryonic heart and liver development, Tbx3 plays an important role in specific lineage choices. For instance, in embryonic heart development, Tbx3 is involved in a lineage choice between pacemaker cells and atrial cardiac cells, in which Tbx3 represses atrial genes in pacemaker cells [35, 36] . Ectopic expression of Tbx3 can impose a pacemaker phenotype on atrial cells [36] , showing that in this context Tbx3 can direct cell fate.
Adult mammary epithelium is actively renewed by stem cells and lineage-restricted progenitors [5] . The bimodal expression of Tbx3 in the luminal lineage, together with the expression of Tbx3 in ER+ progenitors, suggested that Tbx3 may play a role in the lineage choice between the hormone-sensing and the alveolar lineage. Indeed, we found that knockdown of Tbx3 in primary mammary epithelial cells strongly reduced the formation of ER+ cells in mammary reconstitution assays, demonstrating that Tbx3 is required for a hormone-sensing cell fate. We have tried to express a Tbx3 transgene in alveolar progenitor cells to determine if Tbx3 could impose a hormone-sensing cell identity, but we found only few cells that expressed Tbx3 ectopically in vivo (data not shown). This could be due to an anti-proliferative effect of Tbx3 [37] , however ectopic Tbx3 expression in vitro did not prevent proliferation of ER-cells. Therefore, we cannot rule out that the scarcity of Tbx3 overexpressing cells in vivo was due to a technical limitation.
The differential expression of Tbx3 in the luminal lineage raises the question of which signaling pathways influence Tbx3 transcription. Based on other studies using cell lines combined with our observations presented in this study, we can speculate what signals are most likely involved in regulating Tbx3 expression in the intact adult mammary gland. For instance, in ER+ breast cancer cell lines, Tbx3 expression was dependent on both estrogen and FGF signaling [27] . In primary tissue of murine mammary glands, we found a strong correlation between ER and Tbx3 expression and it is therefore plausible that in adult mammary epithelium Tbx3 is downstream of estrogen signaling. It was shown that FGF signaling is required for Tbx3 expression in mammary epithelial cells in the embryo [38] . At this time the three distinct adult lineages do not yet exist [6, 7] and mammary development is hormone independent [3] . FGF signaling is also active in pubertal mammary gland development [39, 40] and we observed strong Tbx3 staining in TEBs, raising the possibility that FGF signaling also contributes to Tbx3 expression in postnatal mammary epithelium. However, ER+ and ER-luminal cells derived from adult mammary glands both express FGF receptors and a downstream target of FGF signaling, Dusp6, is expressed even higher in ER-luminal cells (File S6), and it is therefore unlikely that FGF signaling is responsible for the hormone-sensing cell specific expression of Tbx3.
Another pathway that may contribute to Tbx3 expression is TGFb signaling. In MCF12A cells, a non-transformed mammary epithelial cell line, TGFb directly induced Tbx3 transcription [37] . Notably, TGFb actively inhibits proliferation of MCF12A cells, and also prevents proliferation of ER+ cells in the mammary gland [41] . In MCF12A cells, Tbx3 was required for the antiproliferative effects of TGFb [37] . This is surprising because studies with other cell types suggested an oncogenic role of Tbx3. For instance, Tbx3 was found to directly bind and repress the tumor suppressor Arf in mouse embryonic fibroblasts [42] , thus preventing activation of p53. However, Tbx3 might have other target genes in the mammary gland, since both Arf and p21 expression are robustly detectable on the microarray of sorted primary Tbx3-VenusHigh cells (File S6). Moreover, loss of Arf or p53 did not rescue developmental defects of mammary placodes in Tbx3-mutants [18] . Apart from Arf and p21 not many direct targets for Tbx3 have been described. Tbx3 targets in the mouse heart include genes for gap junctions and ion channels [43] and in embryonic stem cells Tbx3 binds promoters of genes that are also regulated by pluripotency factors [44] , underscoring that Tbx3 likely regulates different target genes depending on the cellular context [21] . Indeed, genes that are repressed by Tbx3 such as Ecadherin in melanoma cells [24] and p21 in promoter assays [45] , are highly expressed in Tbx3-positive mammary epithelial cells ( Figure 4C and File S3). Determining the cistrome of Tbx3 specifically in hormone-sensing cells will likely help to unravel the role of Tbx3 in normal and malignant mammary gland development.
In primary human breast tissue obtained from reduction mammoplasties, Tbx3 expression is also highest in a population of luminal cells that expresses high levels of steroid receptors [13] , indicating that Tbx3 is a marker for hormone-sensing cells in human mammary epithelium as well. Interestingly, this population is also predominantly non-clonogenic [13] , which raises the possibility that Tbx3 has indeed an anti-proliferative role in hormone-sensing cells in normal breast tissue. This would be in line with data from sequencing breast cancer genomes; Tbx3 mutations are found specifically in ER+ breast cancers and these mutations are predicted to result in loss of function [46, 47] . This indicates that Tbx3 might actively prevent tumorigenesis of hormone-sensing cells resulting in selection pressure to lose that function. However, it is possible that in tumors that have retained wildtype Tbx3 expression, Tbx3 is involved in promoting migration [48] or paracrine stimulation of proliferation [27] . Considering these potential conflicting roles of Tbx3 in breast tumorigenesis, it will be important to further characterize the specific role of Tbx3 in breast tissue before considering inhibition of Tbx3 for cancer therapy [49] .
In summary, we provide the first characterization of Tbx3 expression at the single cell level in the adult mammary gland.
By different methods we demonstrate that Tbx3 is highly expressed in the hormone-sensing cell lineage and is functionally required for the generation of hormone-sensing cells during mammary morphogenesis. Our data highlight that Tbx3 is likely to regulate a distinct set of target genes depending on the cellular context. Given the current uncertainty about an anti-or protumorigenic role of Tbx3 in breast cancer, it will be interesting to determine the relevant targets for Tbx3 specifically in hormone-sensing cells. 
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